-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulgent Q1 FY26 net loss widens to $24.8 million; revenue falls to $71.1 million

PUBT·05/01/2026 11:02:04
Listen to the news
Fulgent Q1 FY26 net loss widens to $24.8 million; revenue falls to $71.1 million
  • Fulgent Genetics posted a first-quarter net loss of $24.8 million, or $0.80 per share.
  • Revenue slipped 3.2% to $71.1 million.
  • Adjusted EBITDA loss widened to $15.2 million.
  • Cash, cash equivalents, restricted cash, and investments ended quarter at $604.7 million, excluding an anticipated tax refund of about $106 million.
  • For fiscal year 2026, revenue outlook held at about $350 million, with updated guidance calling for a non-GAAP loss of about $46 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulgent Genetics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605010700BIZWIRE_USPR_____20260501_BW274201) on May 01, 2026, and is solely responsible for the information contained therein.